We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Makers Defend Legality of Reverse Patent Settlements, Urge SCOTUS to Rule Against FTC
Generic Makers Defend Legality of Reverse Patent Settlements, Urge SCOTUS to Rule Against FTC
March 6, 2013
The Supreme Court should let stand an 11th Circuit Court decision that upheld the legality of reverse patent settlements between brand- and generic-drug makers, urge Actavis and Par, which are both parties to the upcoming high court case.